Previous 10 | Next 10 |
Zynex Included in Denver-Area's Top 10 Biotechnology/Bioscience Companies PR Newswire ENGLEWOOD, Colo. , March 21, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive m...
2023-03-13 11:51:02 ET Stocks see-sawed during Monday's intraday session as investors weighed a proposal to backup all of the depositors in the defunct Silicon Valley Bank. Looking at the specific stocks that were making significant moves during the session, ZIM Integrated Ship...
2023-03-13 11:32:06 ET Zynex, Inc. (ZYXI) Q4 2022 Earnings Conference Call March 13, 2023 08:30 ET Company Participants Louisa Smith - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive Officer Dan Moorhead - Chief Financial Officer ...
2023-03-13 11:31:46 ET Zynex ( NASDAQ: ZYXI ) stock rose ~15% on Monday after Q4 earnings beat estimates. Q4 GAAP EPS declined -13% to $0.20, but surpassed estimates. Total net revenue grew +20.9% Y/Y to ~$48.81M, however missed analysts expectations. Devices revenue...
2023-03-13 08:05:47 ET Zynex press release ( NASDAQ: ZYXI ): Q4 GAAP EPS of $0.20 beats by $0.01 . Revenue of $48.8M (+20.9% Y/Y) misses by $0.92M . Adjusted EBITDA of $11.4 million Orders increased 48%; highest number of orders in Company history for the 3...
Zynex Announces 2022 Fourth Quarter and Full Year Earnings PR Newswire ENGLEWOOD, Colo. , March 13, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical ...
NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI ). The investigation concerns whether Zynex and/or certain of its officers have v...
Zynex, Inc. Reschedules Release of Fourth Quarter and Full Year 2022 Financial Results PR Newswire ENGLEWOOD, Colo. , March 10, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) , an innovative medical technology company specializing in the manufacture...
SAN FRANCISCO, CA / ACCESSWIRE / March 9, 2023 / Hagens Berman urges Zynex, Inc. (NASDAQ:ZYXI) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: ZYXI@hbsslaw.com 844-916-0895 Zynex, Inc. (ZY...
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Zynex, Inc. (NASDAQ: ZYXI) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: ZYXI@hbsslaw.com 844-916-0...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...